Research &
Development
 
Independent R&D
Core Technology
Product Pipeline
 
Home >> Research & Development >> Independent R&D
 

Innovation is GenSci's fundamental strategy. GenSci's R&D input accounts for more than12% of the total sales, being in a
leading position at the pharmaceutical industry.
GenSci owns the most advanced biological pilot scale technology platform. The newly developed drugs are all first in China,
partly patented internationally. In the coming three years, GenSci is going to launch six new products, three of them are the
biosimilars, and others are primary new drugs (patented, first in the world).
Innovation and research enable GenSci to successfully develop products of high technology, effective treatment, high safety, multi-formulation and multi-strengths in the field of child growth hormone deficiencies, endocrinology, burns, surgery,
oncology and assistant reproduction.
Particularly, GenLei® Jintropin® is the first and only somatropin in the world to be approved for treatment on burns. GenLei®
Jintropin® AQ is the only approved product for the indication of AGHD. GenSci's core product for the treatment of burns
treatment, GenLei® Genfulin® (gel), is the first in the world.

R&D Milestone 

Year

Product Name

Status
1998

Somatropin (rDNA origin) for Injection, Jintropin®

1st in China

1998

rhG-CSF

The 3rd generation of rhG-CSF, national patent

2001

rhGH new indication approval (treating burns)

Sole in the world

2005

Somatropin (rDNA origin) Injection, Jintropin® AQ

1st in the Asia, 3rd in the world

 2007 

 PEG rhGH Injection

 1st in the world, national patent

2008

 Recombinant thymosin α1

 1st in the world, national patent

2008

 rhGM-CSF Gel

 1st in the world, national patent

R&D Plan

 No.

Therapeutic Area

Expected Launching Time
Status
Gensci  003
Hepatitis, tumor
2013
Patented, 1st in the world
Gensci  006
Pediatric, gynaecologic
2013
1st biosimilar

Gensci  007

Endocrinolgoy
2013
1st biosimilar

Gensci  028

Tumor
2020

1st in the world

 

 
 
 

吉ICP备14004136号-1               GeneScience Pharmaceuticals Co., Ltd. (GenSci)  All Rights Reserved